MICHELLE A FANALE to Health Status
This is a "connection" page, showing publications MICHELLE A FANALE has written about Health Status.
Connection Strength
0.032
-
Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leuk Lymphoma. 2019 11; 60(11):2705-2711.
Score: 0.032